591 therapy is a given.14 months survival in ph2 compared to 5 with Pluvicto and less side affects than Pluvicto.Surprised Novartis has not put a bid in for Telix
- Forums
- ASX - By Stock
- Ann: Telix 2023 Full Year Results and Investor Webcast/Call
591 therapy is a given.14 months survival in ph2 compared to 5...
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$18.25 |
Change
0.100(0.55%) |
Mkt cap ! $6.047B |
Open | High | Low | Value | Volume |
$18.00 | $18.29 | $17.92 | $9.566M | 528.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1646 | $18.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.25 | 26 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 1174 | 18.230 |
14 | 2849 | 18.220 |
10 | 2328 | 18.210 |
9 | 1059 | 18.200 |
10 | 1889 | 18.190 |
Price($) | Vol. | No. |
---|---|---|
18.240 | 881 | 15 |
18.250 | 1358 | 17 |
18.260 | 1245 | 13 |
18.270 | 1273 | 9 |
18.280 | 1771 | 8 |
Last trade - 13.42pm 11/09/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |